Schizophrenia and major depressive disorder (MDD) may be genetically associated with increased risk for constipation but only the latter association appears to be clinically significant, according to ...
A genetic mutation found in two human patients with schizophrenia also increased schizophrenia-related behaviors in mice with ...
Now, new research from the Warren Center for Neuroscience Drug Discovery (WCNDD) offers hope. Scientists have identified a ...
Adding probiotics to antipsychotic treatment is associated with a significant decrease in schizophrenia symptoms, a new ...
Sociologist W.E.B. Du Bois was the psychologist we have never acknowledged. He warned us about double consciousness—psychiatry just called it psychosis.
With clozapine, other problems seem to be overshadowed by the possibility of neutropenia. These include serious conditions such as pneumonia, seizures, myocardiopathy, and constipation. Ileus is ...
CBD has shown promise as a treatment for psychosis in small studies and case reports. A large, international trial launching ...
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA), a biopharmaceutical company focused on developing and commercializing therapies for unmet medical needs, has been navigating a complex landscape of ...
Genome-wide association studies (GWASs) have linked genetic variants to neuropsychiatric disorders, but their regulatory roles in non-coding regions remain largely unclear. Using the LUHMES neuronal ...
During acute episodes, patients may experience psychotic symptoms that impair their ability to control thoughts, emotions and ...
A new study has found that individuals who visit emergency departments (ED) due to hallucinogen use have a significantly higher risk of developing schizophrenia. The research, conducted by scientists ...
Indirect funds are essential for supporting the research infrastructure needed to develop innovative solutions to the most ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results